Australian Biotech CSL Sees Upbeat 2024
Australian biotech giant CSL on Tuesday forecast increased earnings in fiscal 2024 for all its segments on strong demand and cost cutting.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/995464?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/995464?src=rss
Comments
Post a Comment